The Pomegranate (Punica granatum L.), fruit belonging to the Lythraceae family and native to northwestern India, contains several bioactive compounds, such as anthocynins, tannins and phenolic acids. Its phytotherapic attributes involve an antimicrobial, anthelmintic, antioxidant and antiviral activity. This study seeks to analyze the anticarcinogenic effect of pomegranate aqueous extract, through the epithelial tumor (warts) detection in Drosophila melanogaster test. For this purpose, larvae wts+/+mwh were treated with the tumor inducer doxorubicin (0.4mM) and the aqueous extract of pomegranate in the proportions 1:8, 1:4 and 1:2, in isolation and in association with DXR. The results showed that pomegranate did not induce increase in tumor frequency, when compared to the negative control (p>0,05). However, in combinations with doxorubicin, there was a statistically significant reduction (p>0,05) in tumors induced by this chemotherapeutic agent. It is concluded that the aqueous extract of pomegranate, in the experimental conditions proposed in this study, was able to reduce the frequency of tumors, demonstrating their potential use in cancer prevention and therapy.